A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Case Comprehensive Cancer Center
Study ID
NCT07419581
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Dysgeusia
  • Solid Tumor

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MiraBurst — DIETARY_SUPPLEMENT
    Participants will consume one 300 milligram (mg) MiraBurst mini-square prior to each meal (up to four times per day) for a 90 day period.

Study Details

This study is for people with a diagnosis of solid tumor cancer who are experiencing changes in taste perception due to cancer treatment. Changes in taste perception, also known as dysgeusia, is a frequent side effect of cancer treatment and can significantly impacts quality of life. These alterations may be temporary or, in some cases, permanent. The purpose of this study is determine whether freeze dried miracle fruit, marketed as MiraBurst can improve taste perception in this group of people. Participants involved in this study will be asked to take one MiraBurst mini-square upto four times a day, prior to eating, for 90 days.

Key Dates

Start date
Jun 30, 2026
Status verified
Apr 2026
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
45 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: MiraBurst
    Participants will consume one MiraBurst mini-square prior to each meal (up to four times per day) for a 90 day period.

Primary Outcome Measure

Evaluate effect on taste perception [ Time Frame: Baseline (Day 1), Day 7 ]

Central Contacts

  • Shirley Thomas, MD, MRCP (UK), MRCP (UK) Pall Med, PGDip Pall Med
    216-445-0132
    [email protected]

Locations (1)

FacilityCityStateZIPSite coordinators
Cleveland Clinic FoundationClevelandOhio44195
Shirley Thomas, MD MRCP (UK), MRCP (UK) Pall Med, PGDip Pall Med
[email protected]
216-445-0132
Shirley Thomas, MD MRCP (UK), MRCP (UK) Pall Med, PGDip Pall Med (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cleveland, OH

By research site
Cleveland Clinic Foundation· Cleveland, OH

Related Studies